RDHL has been in the news 450% more than usual
Oct 09, 2025, 4:32 PM
-39.57%
What does RDHL do
RedHill Biopharma develops medicines for gastrointestinal and infectious diseases, promoting drugs like Talicia for H. pylori infections and Aemcolo for travelers’ diarrhea. Their late-stage programs include RHB-204, opaganib, RHB-107, RHB-104, and RHB-102.
RDHL has been in the news recently: CREATE Medicines has appointed Allan L. Shaw as CFO and CBO to strengthen its financial strategy for RNA-based immunotherapy. Kedrion Biopharma has introduced YIMMUGO, a 10% intravenous immunoglobulin for treating primary immunodeficiency, now available in the U.S. for patients aged 2 and older.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.